In vitro cell-culture study demonstrates that fenofibrate (used as adjunct to statins to lower cholesterol and lipid levels) reduces severity of coronavirus infection. Human trials to follow to determine if this holds true in vivo. #GoScience

Medical Mythbusting Commentary for August 9, 2021

Source:
Cholesterol drug cuts coronavirus infection by 70%, researchers find

Reference:
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

Bitnami